This is clinical trial to document the efficacy of a proprietary standardized extract of Arctic root in comparison to a standardized commercial extract of ginseng and placebo from an every day consumer perspective to ameliorate mild depression, reduce stress and improve quality of life. A newly developed adaptogenic formulation, Adapt 232, was included into the study in order to evaluate its effect in comparison to the others.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
200
3 Capsules twice a day
3 capsules twice a day
3 capsules twice a day
3 capsules twice a day
Department of Clinical Biochemistry, Frederikbergs Hospital
Frederiksberg, Denmark
Psychological parameters: changes in cognitive functions as measured by the D2 Test of Attention
Time frame: Over a period of 28 days of treatment
Depression parameters: changes in depressive state as measured by the using Hamilton Depression Rating Scale (HAM-D) and Bechs Depression Inventory (BDI).
Time frame: over a period of 28 days of treatment
Quality of Life parameters: changes in quality of life as measured by the SF-36 scale, Danish Stress Profile (SP) test and questions regarding various aspects of well-being as formulated in a non-validated VAS scale
Time frame: Over a period of 28 days of treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.